Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Trial tests safer, more available drug for deadly blood poisoning

NCT ID NCT03248063

Summary

This study aimed to find out if the antibiotic cefazolin works as well as the standard drug cloxacillin for treating a dangerous bloodstream infection called MSSA bacteremia. It involved 315 adults with this infection. Researchers wanted to see if cefazolin could be a safer and more readily available alternative with similar cure rates.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BACTEREMIA DUE TO METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • François-Xavier Lescure

    Paris, 75018, France

Conditions

Explore the condition pages connected to this study.